Benitec Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -631.8% | -631.8% | -304.8% |
| FY2023 | -9,684.2% | -9,684.2% | -438.2% |
| FY2024 | -46.0% | -46.0% | -41.7% |
| FY2025 | -39.0% | -39.0% | -38.1% |
| FY2026 | -25.7% | -25.7% | -24.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -631.8% | -631.8% | -304.8% |
| FY2023 | -9,684.2% | -9,684.2% | -438.2% |
| FY2024 | -46.0% | -46.0% | -41.7% |
| FY2025 | -39.0% | -39.0% | -38.1% |
| FY2026 | -25.7% | -25.7% | -24.9% |